Literature DB >> 19768195

The Howard University Hospital experience with routineized HIV screening: a progress report.

Victor F Scott1, Amy Sitapati, Sayyida Martin, Pamela Summers, Michael Washington, Fernando Daniels, Charles Mouton, George Bonney, Victor Apprey, Virginia Webster, Avemaria Smith, Geoffrey Mountvarner, Monica Daftary, Celia J Maxwell.   

Abstract

BACKGROUND: Howard University Hospital (HUH) is the first hospital in the nation to have instituted a hospital-wide routine rapid HIV screening campaign as recommended by the CDC for healthcare settings.
METHODS: HUH developed a protocol and implemented a hospital-wide routine HIV screening in October 2006. Rapid oral fluid-based HIV testing was conducted throughout the hospital using the OraSure OraQuick Advance Rapid HIV-1/2 Antibody Test. Patients with a preliminarily reactive test result were either referred for confirmatory testing or offered a Western Blot confirmatory test on-site and referred for follow-up care. This is a report on the progress of this program for the first eight months.
RESULTS: Of the 9,817 patients offered HIV testing, 5,642 consented. The mean age of the screened population was 40.7 years. Ninety percent of the patients screened were black and 55% were female. A preliminarily reactive test result was identified in 139 patients for a seroprevalence rate of 2.46%. Of these patients, 136, or 98% were black; 63% were male and 37% were female. HIV prevalence in the overall sample, among blacks, and among both black males and females peaked in the 40-54 year old age group. Challenges were experienced initially in securing confirmatory tests.
CONCLUSIONS: Hospital-wide routine HIV screening is both possible and productive. The routine HIV screening campaign instituted at Howard University Hospital has identified a significant number of previously unidentified HIV positive persons. Success in assuring confirmatory testing and transition to care improved as time progressed.

Entities:  

Mesh:

Year:  2009        PMID: 19768195      PMCID: PMC2744517     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  1 in total

1.  Expanded screening for HIV in the United States--an analysis of cost-effectiveness.

Authors:  A David Paltiel; Milton C Weinstein; April D Kimmel; George R Seage; Elena Losina; Hong Zhang; Kenneth A Freedberg; Rochelle P Walensky
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

  1 in total
  5 in total

1.  Central implementation strategies outperform local ones in improving HIV testing in Veterans Healthcare Administration facilities.

Authors:  Matthew Bidwell Goetz; Tuyen Hoang; Herschel Knapp; Jane Burgess; Michael D Fletcher; Allen L Gifford; Steven M Asch
Journal:  J Gen Intern Med       Date:  2013-04-19       Impact factor: 5.128

2.  Potential Contributions of Clinical and Community Testing in Identifying Persons with Undiagnosed HIV Infection in the United States.

Authors:  James G Kahn; Eran Bendavid; Patricia M Dietz; Angela Hutchinson; Hacsi Horvath; Devon McCabe; Richard J Wolitski
Journal:  J Int Assoc Provid AIDS Care       Date:  2020 Jan-Dec

3.  Missed opportunities: refusal to confirm reactive rapid HIV tests in the emergency department.

Authors:  Ishani Ganguli; Jamie E Collins; William M Reichmann; Elena Losina; Jeffrey N Katz; Christian Arbelaez; Laurel A Donnell-Fink; Rochelle P Walensky
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

4.  Routine HIV testing among providers of HIV care in the United States, 2009.

Authors:  A D McNaghten; Eduardo E Valverde; Janet M Blair; Christopher H Johnson; Mark S Freedman; Patrick S Sullivan
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

5.  Routine HIV testing among hospitalized patients in Argentina. is it time for a policy change?

Authors:  María Eugenia Socías; Laura Hermida; Mariana Singman; Gisela Kulgis; Andrés Díaz Armas; Osvaldo Cando; Omar Sued; Héctor Pérez; Ricardo Hermes; José Luis Presas; Pedro Cahn
Journal:  PLoS One       Date:  2013-07-31       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.